Pharmaron's in vitro biology team helps our partners succeed in target validation, hit identification, hit-to-lead, and lead optimization. Learn more about our drug discovery and development services required for in vitro Biology.

seen from Dominican Republic
seen from United States

seen from Sweden
seen from United Kingdom

seen from Germany

seen from United States
seen from China

seen from United States
seen from Germany

seen from Dominican Republic
seen from United States

seen from United States

seen from Guatemala
seen from China

seen from United States
seen from Netherlands
seen from Jordan

seen from Malaysia
seen from United States

seen from Dominican Republic
Pharmaron's in vitro biology team helps our partners succeed in target validation, hit identification, hit-to-lead, and lead optimization. Learn more about our drug discovery and development services required for in vitro Biology.

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
The Importance of Lead Optimization in Drug Discovery
In the drug discovery process, finding a lead compound represents one of the most important tasks for researchers. Once scientists find a compound that affects the target molecule and passes a series of rigorous safety tests, they begin altering the structure of the compound to enhance certain biological and chemical properties. Often referred to as lead optimization, the alteration process results in safer and more effective compounds. Researchers often begin the lead optimization process by identifying interactions with other biological systems in the body and making the drug less likely to interact with them. By testing hundreds or even thousands of analogues, scientists can greatly decrease the likelihood of side effects. Lead optimization typically involves a significant back-and-forth between biologists, who test the compounds on living systems, and chemists, who make the desired alterations to the drug. At this stage, chemists also begin to consider logistics such as the delivery mechanism, inactive binding agents, and large-scale manufacturing.